Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

American Society of Hematology (ASH 2026) 12 - 15 December 2026

Denecimig (Mim8) efficacy and safety in adults and adolescents with hemophilia A: 2.5-year follow-up from the FRONTIER program

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Congress oral presentation